Metallothionein-3 (MT-3) in the Human Adrenal Cortex and its Disorders
- 365 Downloads
Metallothionein-3 (MT-3) is an intracellular, low molecular weight protein mainly distributed in the central nervous system but also in various peripheral organs and several types of human neoplasms. However, details of MT-3 expression have not been examined in human adrenal cortex and its disorders. The mRNA levels of MT-3 were first evaluated by quantitative RT-PCR (qPCR) in adrenocortical aldosterone-producing adenoma (APA: 11) and cortisol-producing adenoma (CPA: 14). In addition, MT-3 immunohistochemistry was performed in non-pathological adrenal glands (NA: 19), idiopathic hyperaldosteronism (IHA: 10), APA (20), CPA (24), adjacent non-neoplastic adrenal glands of adenoma (AAG: 20), and adrenocortical carcinoma (ACC: 8). H295R cells were also treated with angiotensin-II or forskolin in a time-dependent manner, and the changes of MT-3 mRNA levels were evaluated by qPCR. Results of qPCR analysis demonstrated that MT-3 mRNA levels were significantly higher in APA than CPA (P = 0.0004). MT-3 immunoreactivity was detected in the zona glomerulosa of NA, IHA, and AAG, as well as in APA, CPA, and ACC. When treated with angiotensin-II and forskolin, MT-3 mRNA levels reached a peak by 12 h in H295R cells, with significantly higher levels compared to control non-treated cells (P < 0.01). The presence of MT-3 in the ZG of NA, IHA, and AAG, as well as APA may imply a role in the pathophysiology of aldosterone-producing tissues.
KeywordsAdrenal cortex Zona glomerulosa Adrenocortical adenoma Aldosterone Metallothionein Immunohistochemistry
This work was partly supported by the Takeda Science Foundation and partly supported by the grant for Research on Intractable Diseases from the Japanese Ministry of Health, Labor and Welfare. The first author received scholarship support from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).
- 18.El Ghazi I, Martin BL, Armitage IM. Metallothionein-3 is a component of a multiprotein complex in the mouse brain. Exp Biol Med. 231: 1500–1506, 2006.Google Scholar
- 21.Felizola SJA, Nakamura Y, Hui XG, Satoh F, Morimoto R, M McNamara K, Midorikawa S, Suzuki S, Rainey WE, Sasano H. Estrogen-related receptor α in normal adrenal cortex and adrenocortical tumors: involvement in development and oncogenesis. Mol Cell Endocrinol. 365:207–211, 2013.Google Scholar
- 26.Felizola SJA, Nakamura Y, Satoh F, Morimoto R, Kikuchi K, Nakamura T, Hozawa A, Wang L, Onodera Y, Ise K, McNamara KM, Midorikawa S, Suzuki S, Sasano H. Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: The metabotropic pathway. Mol Cell Endocrinol. 382: 170–177, 2014. doi: 10.1016/j.mce.2013.09.025.PubMedCrossRefGoogle Scholar
- 30.Peyre M, Commo F, Dantas-Barbosa C, Andreiuolo F, Puget S, Lacroix L, Drusch F, Scott V, Varlet P, Mauguen A, Dessen P, Lazar V, Vassal G, Grill J. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. PLoS One. 5(9):e12932, 2010.PubMedCrossRefPubMedCentralGoogle Scholar
- 31.Zhou XD, Sens DA, Sens MA, Namburi VB, Singh RK, Garrett SH, Somji S. Metallothionein-1 and −2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer. Toxicol Sci. 91:467–475, 2006.PubMedCrossRefGoogle Scholar